Andy is a research specialist at Kindeva Drug Delivery, a pharmaceutical contract development and manufacturing organization (CDMO). In this role, he is responsible for driving new ideas and providing broad subject matter expertise to resolve critical issues during complex inhalation product development. He has nearly 20 years of experience within the inhalation field.
Andy represents Kindeva on multiple sub-teams of the European Pharmaceutical Aerosol Group (EPAG), has contributed to several peer-reviewed publications and is the Industrial Advisory Board chair for the School of Science at Loughborough University.
He is a Chartered Chemist within the RSC, and holds a BSc in Medicinal Chemistry from UMIST.